Modern Wearable Defibrillation

Sponsored by Kestra Medical TechnologiesIntroducing the ASSURE WCD

PAID ADVERTISEMENT

The ASSURE® Wearable Cardioverter Defibrillator (WCD) system from Kestra Medical Technologies provides important advantages based on patient-focused design and advanced technology. 

WCDs work when patients wear them, with over 90% survival after an appropriate shock.1, 2, 3  Yet providers report challenges when it comes to patient compliance.

Now, there is a modern approach. 

Kestra designed the ASSURE system to enhance comfort, provide greater clarity to care teams, and increase patient confidence during their recovery after a cardiac event—because compliance matters. 

Welcome to ASSURE.

1 Wäßnig, N.K., et al. Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death. Circulation. 2016;134(9):635-43.

2 Ellenbogen, K.A., et al. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry. JACC. 2017;3(3):243-250/.

3 Chung, M.K., et al. Aggregate National Experience With the Wearable Cardioverter-Defibrillator Vest: Event Rates, Compliance And Survival. Journal of the American College of Cardiology. 2010;56:194-203.


Click here to download.

www.kestramedical.com